Neuroprotective Effect of Low-Intensity Pulsed Ultrasound Against MPP+-Induced Neurotoxicity in PC12 Cells: Involvement of K2P Channels and Stretch-Activated Ion Channels.

Parkinson's disease is the second most common neurodegenerative disease. It is characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta. 1-Methyl-4-phenylpyridinium (MPP+) is a dopaminergic neuronal toxin that is widely used in constructing Parkinson's disease models in vitro. Low-intensity pulsed ultrasound (LIPUS) is a non-invasive therapeutic approach that has neuromodulation and neuroprotective effects in the central neural system; however, whether LIPUS can provide protection for dopaminergic neurons against MPP+-induced neurocytotoxicity remains unknown. In this study, we found that pre-treatment with LIPUS (1 MHz, 50 mW/cm2, 20% duty cycle and 100-Hz pulse repetition frequency, 10 min) inhibited MPP+-induced neurotoxicity and mitochondrial dysfunction in PC12 cells. LIPUS decreased MPP+-induced oxidative stress by modulating antioxidant proteins, including thioredoxin-1 and heme oxygenase-1, and prevented neurocytotoxicity via the phosphoinositide 3-kinase (PI3K)-Akt and ERK1/2 pathways. Furthermore, these beneficial effects were attributed to the activation of K2P channels and stretch-activated ion channels by LIPUS. These data indicate that LIPUS protects neuronal cells from MPP+-induced cell death through the K2P channel- and stretch-activated ion channel-mediated downstream pathways. The data also suggest that LIPUS could be a promising therapeutic method in halting or retarding the degeneration of dopaminergic neurons in Parkinson's disease in a non-invasive manner.

[1]  Xiaodong Wang,et al.  Cytochrome c Promotes Caspase-9 Activation by Inducing Nucleotide Binding to Apaf-1* , 2000, The Journal of Biological Chemistry.

[2]  Linhong Huang,et al.  Neuroprotection by tetrahydroxystilbene glucoside in the MPTP mouse model of Parkinson's disease. , 2013, Toxicology letters.

[3]  A. Choi,et al.  Heme oxygenase-1: function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury. , 1996, American journal of respiratory cell and molecular biology.

[4]  Mark D. Johnson,et al.  Neuronal survival and cell death signaling pathways. , 2002, Advances in experimental medicine and biology.

[5]  M. Barrachina,et al.  MPP+ increases α-synuclein expression and ERK/MAP-kinase phosphorylation in human neuroblastoma SH-SY5Y cells , 2002, Brain Research.

[6]  R. Burke,et al.  Retrograde Axonal Degeneration in Parkinson Disease , 2016, Journal of Parkinson's disease.

[7]  Jiang Peng,et al.  Low-intensity pulsed ultrasound treatment improved the rate of autograft peripheral nerve regeneration in rat , 2016, Scientific Reports.

[8]  L. Greene,et al.  Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[9]  J. Wan,et al.  Ultrasound can modulate neuronal development: impact on neurite growth and cell body morphology. , 2013, Ultrasound in medicine & biology.

[10]  T. Yasuhara,et al.  Glial cell line-derived neurotrophic factor (GDNF) therapy for Parkinson's disease. , 2007, Acta medica Okayama.

[11]  S. Cory,et al.  The Bcl2 family: regulators of the cellular life-or-death switch , 2002, Nature Reviews Cancer.

[12]  A. Crisci,et al.  Low-intensity pulsed ultrasound accelerates the regeneration of the sciatic nerve after neurotomy in rats. , 2002, Ultrasound in Medicine and Biology.

[13]  Jie Bai,et al.  Thioredoxin as a neurotrophic cofactor and an important regulator of neuroprotection , 2004, Molecular Neurobiology.

[14]  A. Letai,et al.  Control of mitochondrial apoptosis by the Bcl-2 family , 2009, Journal of Cell Science.

[15]  E. Melamed,et al.  Transgenic mice expressing human Bcl-2 in their neurons are resistant to 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine neurotoxicity. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[16]  W. Nicklas,et al.  Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. , 1985, Life sciences.

[17]  Xiao-Liang Wang,et al.  Protective effects of TREK-1 against oxidative injury induced by SNP and H2O2 , 2008, Acta Pharmacologica Sinica.

[18]  A. Józkowicz,et al.  Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism , 2016, Cellular and Molecular Life Sciences.

[19]  Y. Mikuni‐Takagaki,et al.  Mechanotransduction activates α₅β₁ integrin and PI3K/Akt signaling pathways in mandibular osteoblasts. , 2011, Experimental cell research.

[20]  Y. Shang,et al.  Erythropoietin prevents PC12 cells from 1-methyl-4-phenylpyridinium ion-induced apoptosis via the Akt/GSK-3β/caspase-3 mediated signaling pathway , 2007, Apoptosis.

[21]  J. Yodoi,et al.  Thioredoxin-1 protects against hyperoxia-induced apoptosis in cells of the alveolar walls. , 2007, Pulmonary pharmacology & therapeutics.

[22]  M. Hennerici,et al.  Ultrasound in the treatment of ischaemic stroke , 2003, The Lancet Neurology.

[23]  H. Nakamura,et al.  Redox regulation by thioredoxin superfamily; protection against oxidative stress and aging , 2000, Free radical research.

[24]  M. Wan,et al.  Low-Intensity Pulsed Ultrasound Enhances Nerve Growth Factor-Induced Neurite Outgrowth through Mechanotransduction-Mediated ERK1/2-CREB-Trx-1 Signaling. , 2016, Ultrasound in medicine & biology.

[25]  Alistair Mathie,et al.  Therapeutic potential of neuronal two-pore domain potassium-channel modulators. , 2007, Current opinion in investigational drugs.

[26]  A. Subramanian,et al.  Integrin-mediated mechanotransduction pathway of low-intensity continuous ultrasound in human chondrocytes. , 2012, Ultrasound in medicine & biology.

[27]  M. Chalfie,et al.  Eukaryotic mechanosensitive channels. , 2010, Annual review of biophysics.

[28]  J. Parks,et al.  The parkinsonian neurotoxin MPP+ opens the mitochondrial permeability transition pore and releases cytochrome c in isolated mitochondria via an oxidative mechanism. , 1999, Biochimica et biophysica acta.

[29]  W. Dauer,et al.  Parkinson's Disease Mechanisms and Models , 2003, Neuron.

[30]  J. Obeso,et al.  Challenges in Parkinson's disease: restoration of the nigrostriatal dopamine system is not enough , 2004, The Lancet Neurology.

[31]  A. Reboreda,et al.  Activation of TREK Currents by the Neuroprotective Agent Riluzole in Mouse Sympathetic Neurons , 2011, The Journal of Neuroscience.

[32]  Y. Seo,et al.  The effect of ultrasound for increasing neural differentiation in hBM-MSCs and inducing neurogenesis in ischemic stroke model. , 2016, Life sciences.

[33]  L. P. van der Heide,et al.  The BCL2 code to dopaminergic development and Parkinson's disease. , 2013, Trends in molecular medicine.

[34]  Andrew Harrison,et al.  Mode & mechanism of low intensity pulsed ultrasound (LIPUS) in fracture repair. , 2016, Ultrasonics.

[35]  M. Matsui,et al.  Early embryonic lethality caused by targeted disruption of the mouse thioredoxin gene. , 1996, Developmental biology.

[36]  H. Masutani,et al.  Critical Roles of Thioredoxin in Nerve Growth Factor-Mediated Signal Transduction and Neurite Outgrowth in PC12 Cells , 2003, The Journal of Neuroscience.

[37]  Wen-zhi Chen,et al.  Upgraded nerve growth factor expression induced by low-intensity continuous-wave ultrasound accelerates regeneration of neurotometicly injured sciatic nerve in rats. , 2010, Ultrasound in medicine & biology.

[38]  Jürgen Götz,et al.  Ultrasound treatment of neurological diseases — current and emerging applications , 2016, Nature Reviews Neurology.

[39]  Daniel Jeanmonod,et al.  First experience with MR-guided focused ultrasound in the treatment of Parkinson's disease , 2014, Journal of therapeutic ultrasound.

[40]  T. Cotter,et al.  Control of mitochondrial integrity by Bcl-2 family members and caspase-independent cell death. , 2004, Biochimica et biophysica acta.

[41]  Jeffrey A. Johnson,et al.  15-Deoxy-Delta(12,14)-prostaglandin J(2) rescues PC12 cells from H2O2-induced apoptosis through Nrf2-mediated upregulation of heme oxygenase-1: potential roles of Akt and ERK1/2. , 2008, Biochemical pharmacology.

[42]  William R Mundy,et al.  Assessment of PC12 cell differentiation and neurite growth: a comparison of morphological and neurochemical measures. , 2004, Neurotoxicology and teratology.

[43]  D. Goldsher,et al.  MRI Guided Focused Ultrasound Thalamotomy for Moderate-to-Severe Tremor in Parkinson's Disease , 2015, Parkinson's disease.

[44]  W. Fu,et al.  Overexpression of Heme Oxygenase-1 Protects Dopaminergic Neurons against 1-Methyl-4-Phenylpyridinium-Induced Neurotoxicity , 2008, Molecular Pharmacology.

[45]  S. Limborska,et al.  Molecular mechanisms of pathogenesis of Parkinson's disease. , 2010, International review of cell and molecular biology.

[46]  M. Beal,et al.  Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases , 2006, Nature.

[47]  Chi-Wei Chang,et al.  Enhancement of Neurotrophic Factors in Astrocyte for Neuroprotective Effects in Brain Disorders Using Low-intensity Pulsed Ultrasound Stimulation , 2015, Brain Stimulation.

[48]  K. Das,et al.  Thioredoxin, a singlet oxygen quencher and hydroxyl radical scavenger: redox independent functions. , 2000, Biochemical and biophysical research communications.

[49]  S. Snyder,et al.  Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[50]  Anders Björklund,et al.  Prospects for new restorative and neuroprotective treatments in Parkinson's disease , 1999, Nature.

[51]  E. Junn,et al.  The role of oxidative stress in Parkinson's disease. , 2013, Journal of Parkinson's disease.

[52]  Peng Xia,et al.  Effects of low-intensity pulsed ultrasound on integrin-FAK-PI3K/Akt mechanochemical transduction in rabbit osteoarthritis chondrocytes. , 2014, Ultrasound in medicine & biology.

[53]  Shing-Hwa Liu,et al.  Ultrasound Enhances the Expression of Brain-Derived Neurotrophic Factor in Astrocyte Through Activation of TrkB-Akt and Calcium-CaMK Signaling Pathways , 2016, Cerebral cortex.

[54]  M. Kitazawa,et al.  Proteolytic Activation of Proapoptotic Kinase PKCδ Is Regulated by Overexpression of Bcl‐2 , 2003 .

[55]  D. Lee,et al.  Astaxanthin protects against MPTP/MPP+-induced mitochondrial dysfunction and ROS production in vivo and in vitro. , 2011, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[56]  S. Markey,et al.  1-Methyl-4-phenylpyridine (MPP+) induces oxidative stress in the rodent. , 1986, Life sciences.

[57]  J. Toldi,et al.  Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders , 2007, Journal of the Neurological Sciences.

[58]  Sadik Esener,et al.  Sonogenetics is a non-invasive approach to activating neurons in Caenorhabditis elegans , 2015, Nature Communications.

[59]  Jianmin Cui,et al.  Ultrasound modulates ion channel currents , 2016, Scientific Reports.

[60]  Young Cheol Na,et al.  Unilateral magnetic resonance–guided focused ultrasound pallidotomy for Parkinson disease , 2015, Neurology.

[61]  C. Jang,et al.  Protective effects of heme oxygenase-1 against MPP+-induced cytotoxicity in PC-12 cells , 2010, Neurological Sciences.

[62]  Feng-Yi Yang,et al.  Protective effects of low-intensity pulsed ultrasound on aluminum-induced cerebral damage in Alzheimer's disease rat model , 2015, Scientific Reports.

[63]  D. Dexter,et al.  Parkinson disease: from pathology to molecular disease mechanisms. , 2013, Free radical biology & medicine.

[64]  M. Beal,et al.  Caspase-9 Activation Results in Downstream Caspase-8 Activation and Bid Cleavage in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Parkinson's Disease , 2001, The Journal of Neuroscience.

[65]  George Perry,et al.  Oxidative stress and neurotoxicity. , 2008, Chemical research in toxicology.

[66]  Nicola Maffulli,et al.  The effects of LIPUS on soft-tissue healing: a review of literature. , 2008, British medical bulletin.

[67]  R. Bakay,et al.  Neurotrophic factor therapy for Parkinson's disease. , 2010, Progress in brain research.

[68]  M. Tanito,et al.  Thioredoxin suppresses 1-methyl-4-phenylpyridinium-induced neurotoxicity in rat PC12 cells , 2002, Neuroscience Letters.

[69]  David S. Park,et al.  Programmed cell death in Parkinson's disease. , 2012, Cold Spring Harbor perspectives in medicine.

[70]  P. Lazarovici,et al.  Signaling Pathways for PC12 Cell Differentiation: Making the Right Connections , 2002, Science.

[71]  Kohei Miyazono,et al.  Mammalian thioredoxin is a direct inhibitor of apoptosis signal‐regulating kinase (ASK) 1 , 1998, The EMBO journal.

[72]  P. Jenner,et al.  Oxidative stress in Parkinson's disease , 2003, Annals of neurology.